EWS/FLI1 oncogene activates caspase 3 transcription and triggers apoptosis in vivo.
EWS/FLI1 oncogene activates caspase 3 transcription and triggers apoptosis in vivo.
复制标题
DOI:
10.1158/0008-5472.can-09-1993
复制
发表时间:
2010-02-01
期刊:
影响因子:
11.2
通讯作者:
Lee SB
中科院分区:
文献类型:
--
作者:
Sohn EJ;Li H;Reidy K;Beers LF;Christensen BL;Lee SB
EWS/FLI1 is a fusion gene product generated by a chromosomal translocation t(q24; q12) found in Ewing sarcoma. EWS/FLI1 encodes an aberrant transcription factor with oncogenic properties in vitro. Paradoxically, expression of EWS/FLI1 in non-transformed primary cells results in apoptosis, but the exact mechanism remains unclear. In primary mouse embryonic fibroblasts (MEFs) derived from conditional EWS/FLI1 knock-in embryos, expression of EWS/FLI1 resulted in apoptosis with concomitant increase in the endogenous Caspase 3 (Casp3) mRNA. EWS/FLI1 directly bound and activated the CASP3 promoter, while siRNA-mediated knockdown of EWS/FLI1 led to a marked decrease in CASP3 transcripts in Ewing sarcoma cell lines. Ectopic expression of EWS/FLI1 resulted in an increased expression of CASP3 protein in heterologous cell lines. Importantly, expression of EWS/FLI1 in the mouse triggered an early onset of apoptosis in kidneys and acute lethality. These findings suggest that EWS/FLI1 induces apoptosis, at least partially, through the activation of CASP3 and demonstrate the cell-context dependent roles of EWS/FLI1 in apoptosis and tumorigenesis.